Immunocyte
We are currently developing NK cell therapies, focusing on advanced culture methods that use cell-derived additives such as cytokines, instead of relying on cancer antigen-based culture methods. We are also investigating large-scale culture processes for NK cells.
Stem Cell
We are developing treatments using umbilical cord-derived stem cells and have secured proprietary technology to separate, regulate, and preserve autologous stem cells according to their characteristics. With our specialized technology, personalized cell processing is made possible.
International Patient Services
BH Biotech continues to grow through global partnerships and is dedicated to providing high-quality medical services for patients worldwide.
Cell Banking
We have state-of-the-art technology for isolating and culturing immune cells from peripheral blood.

Korea
china
